Osimertinib(CAS: 1421373-65-0)

Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in cancer treatment. It has the chemical formula C24H28N2O and is known for its high selectivity against EGFR mutations, particularly T790M. Osimertinib is a potent and well-tolerated medication for the treatment of non-small cell lung cancer (NSCLC).

Osimertinib is primarily used in oncology to treat non-small cell lung cancer (NSCLC) that has developed resistance to first- or second-generation EGFR inhibitors. It is also used in research for studying EGFR-targeted therapies and in pharmaceutical development for creating similar cancer treatments. Its applications include targeted therapy and personalized medicine for patients with specific genetic mutations.

Osimertinib is generally considered safe when used as directed, but it may cause side effects such as diarrhea, rash, and fatigue. Proper handling and adherence to safety guidelines are essential to minimize risks. It is regulated by safety standards to ensure its use in medical settings is appropriate and effective.

Osimertinib should be stored in a cool, dry place away from direct light. It is typically kept at a temperature between 15°C to 30°C (59°F to 86°F) and in airtight containers to maintain stability and potency. Avoid exposure to moisture and high humidity to prevent degradation of the compound.